We strive to maximize the impact and reach of our transformative therapies
Leveraging the global competitiveness and differentiated strengths of our pipeline to establish global collaborations through diverse approaches, accelerating global commercialization to benefit patients worldwide
NewCo
Establish joint ventures with venture capital firms to consolidate resources, technologies, and expertise, propelling the advancement of drug development and innovation
Out-Licensing
Establish strategic partnerships and grant exclusive licenses for rights outside Greater China, enabling patients worldwide to benefit from our R&D outcomes
Collaborative Development
Establish co-development partnerships to share resources and technologies, accelerating the development and commercialization of revolutionary therapies
Global Partner
Cooperation for providing patients with better treatment options
